HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $478,337,000,000 | 76.20% |
| venBio Partners LLC | 2,740,411 | $116,851,000 | 21.05% |
| Vivo Capital, LLC | 4,884,341 | $208,268,000 | 12.56% |
| HealthInvest Partners AB | 195,000 | $8,315,000 | 11.72% |
| Nan Fung Group Holdings Ltd | 768,708 | $32,778,000 | 9.70% |
| Aisling Capital Management LP | 355,415 | $15,155,000 | 5.35% |
| ASHFORD CAPITAL MANAGEMENT INC | 694,783 | $29,626,000 | 2.95% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 236,000 | $10,063,000 | 2.24% |
| Newlight Partners LP | 900,824 | $38,411,000 | 2.12% |
| MPM BioImpact LLC | 142,437 | $6,074,000 | 1.11% |